Elizabeth Laws, n/a

Global Head of Sanofi Integrated Launch Capabilities (SILC)
Sanofi, Cambridge

Poster(s):

• (239) Dupilumab efficacy in patients with Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation with and without Emphysema
  Wednesday, October 29, 2025